DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Bystolic (Nebivolol) - Headache - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Headache (11)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Bystolic (Nebivolol) where reactions include headache. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Bystolic side effects in male

Reported by a consumer/non-health professional from United States on 2012-08-08

Patient: male

Reactions: Asthma, Headache, Gastric Ulcer, Fatigue, Neuropathy Peripheral, Depression, Myocardial Infarction, Pneumonia, Haemorrhoids, Acquired Immunodeficiency Syndrome, Hernia, Cerebrovascular Accident, Cushing's Syndrome, Bronchitis Chronic, Epididymitis, Cardiac Arrest

Drug(s) suspected as cause:
Folic Acid

Fluorouracil
    Dosage: every 12 hours

Norvir

Acyclovir

Crestor
    Administration route: Oral

Multi-Vitamin
    Dosage: daily

Spironolactone

Bupropion Hydrochloride

Prochlorperazine

Oxegen
    Dosage: 2 liters while sleeping and as needed

Isentress

Albuterol Sulfate and Ipratropium Bromide
    Dosage: 3/5 mg three times a day

Bystolic

Neurontin
    Dosage: 300 mg three times a day as needed

Prilosec
    Administration route: Oral

Aspirin

Prezista

Fosamax

Plavix

Vitamin D

Testosterone

Lasix
    Dosage: 40 mg daily and as needed

MAG Oxide Cypress



Possible Bystolic side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-20

Patient: female, weighing 63.5 kg (139.7 pounds)

Reactions: Abdominal Pain, Weight Decreased, Urinary Incontinence, Blood Triglycerides Increased, Blood Count Abnormal, Headache, Micturition Frequency Decreased, Erythema, Loss of Consciousness, Palpitations, Dizziness, Arterial Occlusive Disease, Gallbladder Disorder, TOE Operation, Kidney Infection, Blood Pressure Increased, Anaemia, Lung Neoplasm, Cystitis, Hypoaesthesia, Cerebrovascular Accident, Gastric Disorder, Full Blood Count Decreased, Burning Sensation, Haemoglobin Decreased, Carbuncle, Cholecystectomy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bystolic
    Dosage: (df)
    Indication: Product Used FOR Unknown Indication

Macrobid
    Dosage: (df)
    Indication: Product Used FOR Unknown Indication

Lisinopril
    Dosage: (df)
    Indication: Product Used FOR Unknown Indication

Losartan Potassium
    Dosage: (df)
    Indication: Product Used FOR Unknown Indication

Levaquin
    Dosage: (df)
    Indication: Product Used FOR Unknown Indication

Cardizem
    Dosage: (df)
    Indication: Product Used FOR Unknown Indication

Cardizem
    Dosage: (df)
    Indication: Flushing

Cipro
    Dosage: (df)
    Indication: Product Used FOR Unknown Indication

Depakote
    Dosage: (df)
    Indication: Convulsion
    Start date: 1995-01-01
    End date: 2004-01-01

Norvasc
    Dosage: see image
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-07-19
    End date: 2011-07-21

Norvasc
    Dosage: see image
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-07-22

Norvasc
    Dosage: see image
    Administration route: Oral
    Indication: Hypertension
    Start date: 1994-01-01

Norvasc
    Dosage: see image
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-01-01

Norvasc
    Dosage: see image
    Administration route: Oral
    Indication: Hypertension
    Start date: 1997-01-01

Hydrochlorothiazide
    Dosage: (df)
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-03-07

Xanax
    Dosage: (0.5 dosage form daily)
    Indication: Product Used FOR Unknown Indication

Avapro
    Dosage: (df)
    Indication: Hypertension

Benicar
    Dosage: (df oral)
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-01-01

Bactrim
    Dosage: (df)
    Indication: Product Used FOR Unknown Indication

Diovan
    Dosage: (df)
    Indication: Product Used FOR Unknown Indication

Furosemide
    Dosage: (df)
    Indication: Product Used FOR Unknown Indication

Atacand
    Dosage: (32 mg qd oral)
    Administration route: Oral
    Indication: Hypertension
    Start date: 1995-01-01

Lidocaine Hydrochloride
    Dosage: (df; one time)
    Indication: Paronychia
    Start date: 2010-05-13
    End date: 2010-05-13

Dilantin
    Dosage: (df)
    Indication: Convulsion
    Start date: 1995-01-01

Reglan
    Dosage: (df)
    Indication: Product Used FOR Unknown Indication

Toprol-XL
    Dosage: (50 mg bid)
    Indication: Heart Rate Abnormal

Nopalea - Plant Alkaloids and Other Natural Products
    Dosage: (df)
    Start date: 2010-01-01

Other drugs received by patient: Levothyroxine Sodium; Clonidine



Possible Bystolic side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-12

Patient: female, weighing 68.0 kg (149.7 pounds)

Reactions: Weight Decreased, Blood Count Abnormal, Drug Interaction, Headache, Erythema, Loss of Consciousness, Myocardial Calcification, Palpitations, Dizziness, Ingrowing Nail, Abdominal Distension, TOE Operation, Blood Pressure Increased, Cystitis, Burning Sensation, Insomnia, Cholecystectomy

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Xanax
    Dosage: (1/2 tablet qd)
    Indication: Product Used FOR Unknown Indication

Macrobid
    Indication: Product Used FOR Unknown Indication

Diovan
    Indication: Product Used FOR Unknown Indication

Lidocaine
    Indication: Anaesthesia
    Start date: 2010-05-13
    End date: 2010-05-13

Losartan Potassium
    Indication: Product Used FOR Unknown Indication

Cardizem
    Indication: Product Used FOR Unknown Indication

Reglan
    Indication: Product Used FOR Unknown Indication

Furosemide
    Indication: Product Used FOR Unknown Indication

Benicar
    Dosage: per oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-01-01

Bactrim
    Indication: Product Used FOR Unknown Indication

Hydrochlorothiazide
    Indication: Product Used FOR Unknown Indication

Bystolic
    Indication: Product Used FOR Unknown Indication

Avapro
    Indication: Hypertension

Norvasc
    Dosage: 2.5 mg (2.5 mg, qd), oral 5 mg (5 mg, qd), oral 10 mg, (5 mg, bid), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 1994-01-01

Norvasc
    Dosage: 2.5 mg (2.5 mg, qd), oral 5 mg (5 mg, qd), oral 10 mg, (5 mg, bid), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 1997-01-01

Norvasc
    Dosage: 2.5 mg (2.5 mg, qd), oral 5 mg (5 mg, qd), oral 10 mg, (5 mg, bid), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-01-01

Lisinopril
    Indication: Product Used FOR Unknown Indication

Levaquin
    Indication: Product Used FOR Unknown Indication

Atacand
    Dosage: 32 mg (32 mg)
    Indication: Renal Disorder
    Start date: 1995-01-01

Ciprofloxacin
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Levothyroxine Sodium; Toprol (Metoprolol Succinate) (Metoprolol Succinate); Clonidine



Possible Bystolic side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-21

Patient: female

Reactions: Blood Pressure Increased, Weight Decreased, Blood Count Abnormal, Headache, Cystitis, Loss of Consciousness, Burning Sensation, Palpitations, Ingrowing Nail, Abdominal Distension, Cholecystectomy, Dizziness, Arteriosclerosis Coronary Artery, TOE Operation

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dilantin
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 1996-01-01

Xanax
    Dosage: 0.5 df, qd
    Indication: Product Used FOR Unknown Indication

Macrobid
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Hydrochlorothiazide
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Reglan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Levaquin
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Depakote
    Dosage: unk
    Indication: Convulsion
    Start date: 1996-01-01

Avapro
    Dosage: unk
    Indication: Hypertension

Ciprofloxacin HCL
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Lidocaine
    Dosage: unk
    Indication: Anaesthesia
    Start date: 2010-05-13
    End date: 2010-05-13

Lisinopril
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Furosemide
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Losartan Potassium
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Benicar
    Dosage: unk
    Administration route: Oral
    Indication: Hypertension
    Start date: 2007-01-01

Cardizem
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Atacand
    Dosage: 32 mg, unk
    Indication: Product Used FOR Unknown Indication

Norvasc
    Dosage: 2.5 mg, qd
    Administration route: Oral
    Indication: Blood Pressure Increased
    Start date: 2010-07-19
    End date: 2010-07-21

Norvasc
    Dosage: 5 mg, bid
    Administration route: Oral
    Start date: 2010-01-01

Diovan
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Norvasc
    Dosage: 5 mg, qd
    Administration route: Oral
    Start date: 1997-01-01

Bystolic
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Bactrim
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Levothyroxine Sodium; Clonidine



Possible Bystolic side effects in female

Reported by a physician from United States on 2012-05-17

Patient: female, weighing 93.0 kg (204.5 pounds)

Reactions: Headache, Constipation, Disease Progression, Fatigue, Depression, Decreased Appetite, Swelling Face, Vulvovaginal Mycotic Infection, Stomatitis, Nausea, Chromaturia, Dysgeusia, Mucosal Inflammation, Epigastric Discomfort, Oral Pain, Platelet Count Decreased, Vaginal Infection, Asthenia, Hypertension, Oral Fungal Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sutent
    Dosage: 25 mg, unk
    Start date: 2012-01-01

Sutent
    Dosage: 50 mg, 1x/day (28 days cycle)
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2012-01-31
    End date: 2012-03-01

Bystolic
    Dosage: unk
    Indication: Hypertension

Sutent
    Dosage: 50 mg, daily (28 days cycle and 2 weeks off)
    Administration route: Oral
    Indication: Renal Cancer
    Start date: 2012-03-16
    End date: 2012-01-01

Sutent
    Dosage: 50 mg, 28 days
    Administration route: Oral
    Start date: 2012-02-01
    End date: 2012-01-01

Other drugs received by patient: Tylenol (Caplet); Losartan Potassium



Possible Bystolic side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-16

Patient: female, weighing 96.1 kg (211.5 pounds)

Reactions: Headache, Fatigue, Depression, Decreased Appetite, Vulvovaginal Mycotic Infection, Stomatitis, Swelling Face, Nausea, Thyroid Cancer, Chromaturia, Dysgeusia, Mucosal Inflammation, Oral Pain, Neoplasm Malignant, Epigastric Discomfort, Vaginal Infection, Asthenia, Hypertension, Oral Fungal Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sutent
    Dosage: 50 mg, 1x/day (28 days cycle)
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2012-01-30
    End date: 2012-03-01

Sutent
    Dosage: 50 mg, 28 days
    Administration route: Oral
    Start date: 2012-02-01
    End date: 2012-01-01

Bystolic
    Dosage: unk
    Indication: Hypertension

Sutent
    Dosage: 50 mg, 1x/day
    Administration route: Oral
    Indication: Renal Cancer
    Start date: 2012-03-16
    End date: 2012-01-01

Sutent
    Dosage: 25 mg, unk
    Start date: 2012-01-01

Other drugs received by patient: Tylenol (Caplet)



Possible Bystolic side effects in female

Reported by a consumer/non-health professional from United States on 2012-05-02

Patient: female, weighing 96.1 kg (211.5 pounds)

Reactions: Headache, Fatigue, Depression, Decreased Appetite, Stomatitis, Swelling Face, Vulvovaginal Mycotic Infection, Nausea, Thyroid Cancer, Chromaturia, Dysgeusia, Mucosal Inflammation, Epigastric Discomfort, Neoplasm Malignant, Oral Pain, Vaginal Infection, Hypertension, Asthenia, Oral Fungal Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Sutent
    Dosage: 50 mg, 1x/day (28 days cycle)
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2012-01-30
    End date: 2012-03-01

Sutent
    Dosage: 50 mg, 1x/day
    Administration route: Oral
    Indication: Renal Cancer
    Start date: 2012-03-16
    End date: 2012-01-01

Sutent
    Dosage: 50 mg, 28 days
    Administration route: Oral
    Start date: 2012-02-01
    End date: 2012-01-01

Sutent
    Dosage: 25 mg, unk
    Start date: 2012-01-01

Bystolic
    Dosage: unk
    Indication: Hypertension

Other drugs received by patient: Tylenol (Caplet)



Possible Bystolic side effects in 43 year old male

Reported by a physician from United States on 2012-01-27

Patient: 43 year old male, weighing 155.6 kg (342.3 pounds)

Reactions: Cellulitis, Headache, Erythema, Fall, Amnesia, Onychalgia, Lymphadenitis, Syncope, Staphylococcal Infection, Unevaluable Event, Depression, Bradycardia, Skeletal Injury

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Bystolic
    Dosage: 5 mg (5 mg, 1 in 1 d), oral, 10 mg (10 mg, 1 in 1 d), oral, 5 mg (5 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-11-19
    End date: 2008-12-01

Bystolic
    Dosage: 5 mg (5 mg, 1 in 1 d), oral, 10 mg (10 mg, 1 in 1 d), oral, 5 mg (5 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2008-12-02
    End date: 2009-05-26

Bystolic
    Dosage: 5 mg (5 mg, 1 in 1 d), oral, 10 mg (10 mg, 1 in 1 d), oral, 5 mg (5 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2009-05-28
    End date: 2009-06-04

Bystolic
    Dosage: 10 mg (10 mg, 1 in 1 d), oral
    Administration route: Oral
    Indication: Hypertension
    Start date: 2009-06-05
    End date: 2009-06-16

Other drugs received by patient: Fentanyl; Clobetasol (Clobetasol); Dilaudud (Hydromorphone Hydrochloride) (Hydromorphone Hydrochloride); Xanax; Ambien; Cymbalta (Duloxetine Hydrochloride) Duloxetine Hydrochloride); Mobic; Neurontin; Zaroxolyn (Metolazone) (Metolazone); Midrin (Isocom) (Isocom); Soma (Carisoprodol) (Carisoprodol); Tarka (Udramil) (Udramil); Vicodin (Vicodin) (Vicodin); Ultram (Tramadol Hydrochloride) (Tramadol Hydrochloride); Aleve (Naproxen Sodium) (Naproxen Sodium); Ambien CR (Zolpidem Tartrate) (Zolpidem Tartrate); Glucophage (Metformin Hydrochloride) (Metformin Hydrochloride); Lotrel (Lotrel) (Lotrel)



Possible Bystolic side effects in 27 year old male

Reported by a physician from United States on 2012-01-17

Patient: 27 year old male, weighing 84.8 kg (186.6 pounds)

Reactions: Headache

Adverse event resulted in: death

Drug(s) suspected as cause:
Bystolic
    Dosage: 5 mg ; 5 mg (5 mg)
    Indication: Hypertension
    Start date: 2011-03-23
    End date: 2011-06-23

Bystolic
    Dosage: 5 mg ; 5 mg (5 mg)
    Indication: Hypertension
    Start date: 2011-12-08
    End date: 2011-12-12



Possible Bystolic side effects in 70 year old female

Reported by a consumer/non-health professional from United States on 2011-12-06

Patient: 70 year old female

Reactions: Pain in Extremity, Heart Rate Increased, Heart Rate Irregular, Headache, Hypoaesthesia

Drug(s) suspected as cause:
Cefdinir
    Indication: Bronchitis
    Start date: 2011-05-02

Bystolic
    Administration route: Oral
    Indication: Hypertension
    Start date: 2011-05-02
    End date: 2011-05-08

Bystolic
    Administration route: Oral
    Start date: 2011-04-01
    End date: 2011-04-01



Possible Bystolic side effects in female

Reported by a consumer/non-health professional from United States on 2011-12-02

Patient: female, weighing 63.5 kg (139.7 pounds)

Reactions: Abdominal Pain, Weight Decreased, Wrong Technique in Drug Usage Process, Urinary Incontinence, Blood Triglycerides Increased, Blood Count Abnormal, Micturition Frequency Decreased, Headache, Erythema, Loss of Consciousness, Palpitations, Blood Pressure Inadequately Controlled, Ingrowing Nail, Dizziness, Arterial Occlusive Disease, Gallbladder Disorder, Splenomegaly, Kidney Infection, Anaemia, Lung Neoplasm, Arteriogram Coronary Abnormal, Cystitis, Hypoaesthesia, Gastric Disorder, Full Blood Count Decreased, Burning Sensation, Carbuncle, Insomnia, Platelet Count Decreased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Diovan
    Dosage: df
    Indication: Product Used FOR Unknown Indication

Bactrim
    Dosage: df
    Indication: Product Used FOR Unknown Indication

Lisinopril
    Dosage: df
    Indication: Product Used FOR Unknown Indication

Hydrochlorothiazide
    Dosage: df
    Indication: Product Used FOR Unknown Indication

Bystolic
    Dosage: df
    Indication: Product Used FOR Unknown Indication

Atacand
    Dosage: 32 mg qd oral, 16 mg qd oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 1996-01-01

Losartan Potassium
    Dosage: df
    Indication: Product Used FOR Unknown Indication

Reglan
    Dosage: df
    Indication: Product Used FOR Unknown Indication

Xanax
    Dosage: 0.5 dosage form daily
    Indication: Product Used FOR Unknown Indication

Norvasc
    Dosage: 2.5 mg qd oral, 5 mg qd oral, 2.5 mg oral, half of a 5 mg tablet oral, half of a 5 mg tablet oral, 5
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-01-01

Norvasc
    Dosage: 2.5 mg qd oral, 5 mg qd oral, 2.5 mg oral, half of a 5 mg tablet oral, half of a 5 mg tablet oral, 5
    Administration route: Oral
    Indication: Hypertension
    Start date: 1995-01-01

Norvasc
    Dosage: 2.5 mg qd oral, 5 mg qd oral, 2.5 mg oral, half of a 5 mg tablet oral, half of a 5 mg tablet oral, 5
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-07-22

Norvasc
    Dosage: 2.5 mg qd oral, 5 mg qd oral, 2.5 mg oral, half of a 5 mg tablet oral, half of a 5 mg tablet oral, 5
    Administration route: Oral
    Indication: Hypertension
    Start date: 1997-01-01

Norvasc
    Dosage: 2.5 mg qd oral, 5 mg qd oral, 2.5 mg oral, half of a 5 mg tablet oral, half of a 5 mg tablet oral, 5
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-07-19
    End date: 2011-07-21

Macrobid
    Dosage: df
    Indication: Product Used FOR Unknown Indication

Benicar
    Dosage: df
    Administration route: Oral
    Indication: Hypertension
    End date: 2007-01-01

Avapro
    Dosage: df
    Indication: Hypertension

Ciprofloxacin Hydrochloride
    Dosage: df
    Indication: Product Used FOR Unknown Indication

Lidocaine HCL
    Dosage: df
    Indication: Paronychia
    Start date: 2010-05-13
    End date: 2010-05-13

Cardizem
    Dosage: df
    Indication: Product Used FOR Unknown Indication

Furosemide
    Dosage: df
    Indication: Product Used FOR Unknown Indication

Levaquin
    Dosage: df
    Indication: Product Used FOR Unknown Indication

Depakote
    Dosage: df
    Indication: Convulsion
    Start date: 1996-01-01

Dilantin
    Dosage: df
    Indication: Product Used FOR Unknown Indication
    Start date: 1996-01-01

Other drugs received by patient: Clonidine; Levothyroxine Sodium

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017